Sami Heikkinen

Dr. Sami Heikkinen


Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 August 2010 in Magnetic Resonance in Chemistry
Verified
Journal Article
Closed access
PDF file
JKJari S. Kavakka
Jari S. Kavakka
VPViktor Parviainen
Viktor Parviainen
KWKristiina Wähälä
Kristiina Wähälä
IKIlkka Kilpeläinen
Ilkka Kilpeläinen
SHSami Heikkinen
Sami Heikkinen

24 March 2009 in BMC Structural Biology
Verified
Journal Article
Open access
PDF file
OHOuti Heikkinen
Outi Heikkinen
RSRaili Seppala
Raili Seppala
HTHelena Tossavainen
Helena Tossavainen
SHSami Heikkinen
Sami Heikkinen
HKHarri Koskela
Harri Koskela
IKIlkka Kilpeläinen
Ilkka Kilpeläinen
Background: Staphylococcus aureus is a Gram-positive pathogenic bacterium causing many kinds of infections from mild respiratory tract infections to life-threatening states as sepsis. Recent emergence of S. aureus strains resistant to numerous antibiotics has created a need for new antimicrobial agents and novel drug targets. S. aureus PrsA is a membrane associated extra-cytoplasmic lipoprotein which contains a parvulin-type peptidyl-prolyl cis-trans isomerase domain. PrsA is known to act as an essential folding factor for secreted proteins in Gram-positive bacteria and thus it is a potential target for antimicrobial drugs against S. aureus. Results: We have solved a high-resolution solution structure of the parvulin-type peptidyl-prolyl cis-trans isomerase domain of S. aureus PrsA (PrsA-PPIase). The results of substrate peptide titrations pinpoint the active site and demonstrate the substrate preference of the enzyme. With detailed NMR spectroscopic investigation of the orientation and tautomeric state of the active site histidines we are able to give further insight into the structure of the catalytic site. NMR relaxation analysis gives information on the dynamic behaviour of PrsA-PPIase. Conclusion: Detailed structural description of the S. aureus PrsA-PPIase lays the foundation for structure-based design of enzyme inhibitors. The structure resembles hPin1-type parvulins both structurally and regarding substrate preference. Even though a wealth of structural data is available on parvulins, the catalytic mechanism has yet to be resolved. The structure of S. aureus PrsA-PPIase and our findings on the role of the conserved active site histidines help in designing further experiments to solve the detailed catalytic mechanism.

31 July 2018 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
DCDaniel Rico del Cerro
Daniel Rico del Cerro
RMRaúl Mera-Adasme
Raúl Mera-Adasme
AKAlistair King
Alistair King
JPJesus Enrique Perea-Buceta
Jesus Enrique Perea-Buceta
SHSami Heikkinen
Sami Heikkinen
KWKristiina Wähälä
Kristiina Wähälä

27 January 2015 in RSC Advances
Verified
Journal Article
Closed access
PDF file
MSM. Soikkeli
M. Soikkeli
KSK. Sievänen
K. Sievänen
JPJ. Peltonen
J. Peltonen
TKTouko Kaasalainen
Touko Kaasalainen
MTM. Timonen
M. Timonen
SHSami Heikkinen
Sami Heikkinen
Two organic radical contrast agents, TEMPO-Glc and TEEPO-Glc, were synthesized and their stabilities and contrast enhancing properties were tested with in vitro NMR and MRI experiments. Owing to the glucose moieties in the prepared compounds, this study presents potential candidates for a tumor targeting fully organic contrast agents for MRI.

27 April 2018 in Molecules
Verified
Journal Article
Open access
PDF file
MSMaiju Soikkeli
Maiju Soikkeli
KHKaisa Horkka
Kaisa Horkka
JMJani Moilanen
Jani Moilanen
MTMarjut Timonen
Marjut Timonen
JKJari Kavakka
Jari Kavakka
SHSami Heikkinen
Sami Heikkinen
Cancer is a widespread and life-threatening disease and its early-stage diagnosis is vital. One of the most effective, non-invasive tools in medical diagnostics is magnetic resonance imaging (MRI) with the aid of contrast agents. Contrast agents that are currently in clinical use contain metals, causing some restrictions in their use. Also, these contrast agents are mainly non-specific without any tissue targeting capabilities. Subsequently, the interest has notably increased in the research of organic, metal-free contrast agents. This study presents a new, stable organic radical, TEEPO-Met, where a radical moiety 2,2,6,6-tetraethylpiperidinoxide (TEEPO) is attached to an amino acid, methionine (Met), as a potentially tumour-targeting moiety. We describe the synthesis, stability assessment with electron paramagnetic resonance (EPR) spectroscopy and relaxation enhancement abilities by an in vitro nuclear magnetic resonance (NMR) and phantom MRI studies of TEEPO-Met. The new compound proved to be stable notably longer than the average imaging time in conditions mimicking a biological matrix. Also, it significantly reduced the relaxation times of water, making it a promising candidate as a novel tumour targeting contrast agent for MRI.

1 October 2016 in Journal of Magnetic Resonance
Verified
Journal Article
Closed access
VMValtteri Mäkelä
Valtteri Mäkelä
JHJussi Helminen
Jussi Helminen
IKIlkka Kilpeläinen
Ilkka Kilpeläinen
SHSami Heikkinen
Sami Heikkinen